Between a rock and a hard place: a high-risk patient with resistance to multiple P2Y12 antagonists
{{output}}
Impaired response to P2Y12 receptor antagonists, such as clopidogrel and prasugrel, can have devastating consequences for patients that require prolonged or indefinite therapy with these agents, including those with a left ventricular assist device (LVAD). Whi... ...
